Advancing cancer biomarker detection

Researchers leverage novel biomarker detection techniques to transform cancer diagnosis and treatment management. 

Molecular biomarkers offer a wealth of information that facilitates accurate cancer diagnosis and guides treatment strategies. Recent technological advances have unlocked the identification of diverse biomarker types, including extracellular vesicles (EVs), proteins, carbohydrates, DNA, and RNA. In this seminar, Anton Iliuk, Brian Haab, Yong Zeng, and Brian Cunningham will discuss innovative approaches to detect biomarkers for cancer diagnosis, prognosis, and treatment assessment. 

Topics to be covered

  • Developing non-invasive cancer diagnostics using EV protein biomarkers 
  • Probing glycan biomarkers for pancreatic cancer diagnosis and prognosis
  • Engineering biosensors to profile EV biomarkers for cancer liquid biopsy
  • Designing point-of-care cancer diagnostics for therapy monitoring

Wednesday, September 20th, 2023 | 1:30 PM - 4:00 PM Eastern Time
This seminar will be available to view live and on demand.


Anton Iliuk, PhD

Anton Iliuk, PhD 

President and Chief Technology Officer 
Tymora Analytical Operations

Brian Haab, PhD

Brian Haab, PhD

Van Andel Institute

Yong Zeng, PhD

Yong Zeng, PhD

Associate Professor
University of Florida

Brian T. Cunningham, PhD

Brian Cunningham, PhD

Intel Alumni Endowed Chair
University of Illinois at Urbana Champaign

Supported by